Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA for Mild to Moderate Liver Fibrosis (Single-arm Phase 4 Study)
ChiCTR2600127086Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tauroursodeoxycholic acid in hepatic fibrosis, sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Liver stiffness measurement (LSM). Started Jan 2026; status: recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
hepatic fibrosis
Beyond the preview
Go deeper on ChiCTR2600127086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127086.